[Ip-health] ACTA briefing by De Gucht in the European Parliament

Malini Aisola malini.aisola at keionline.org
Tue Jul 13 14:22:27 PDT 2010


ACTA briefing by De Gucht in the European Parliament

By Malini Aisola
Created 13 Jul 2010 - 2:45pm

This week, the European Commission conducted two briefings for members
of the European Parliament. 

On Monday, July 12, members of the European Parliament's INTA Committee
(Committee on International Trade) were briefed by EU ACTA negotiators
Luc Devigne and Pedro Valesco in a private, closed meeting.

Today, July 13, Karel De Gucht, EU Commissioner for Trade held a public
briefing in the LIBE Committee (Committee on Civil Liberties, Justice
and Home Affairs). The video is now available here [1] 

During the meeting, De Gucht informed that the next round of
negotiations will take place at the end of this month in Washington DC.
Other sources in Brussels have also informed that a negotiating round is
also tentatively planned for Japan in September. 

Note the following:

      * De Gucht on detention of generic medicines and reference to
        India and Brazil actions at WTO and ACTA (5:00 minutes)
      * MEP Ska Keller's intervention on public access to documents,
        information about which party opposed the text's public release
        during the Lucerne round; ask for impact studies for access to
        medicines or technology transfer; raises concerns about patents
        in the civil enforcement section and injunctions provisions in
        ACTA that are more restrictive than TRIPS, still a threat for
        access to medicines; need for safeguard guarantees in the text
        (at 13:25 minutes)
      * De Gucht on transparency and party opposing transparency(20:30)
      * De Gucht response on ACTA's impact on access to medicines and
        reference to Indian WTO case on seizures (at 23:30 minutes)
      * De Gucht messy response on impact studies (25 minutes)
      * De Gucht on "hypocrisy" of the US, disagreement over inclusion
        of geographical indicators and industrial designs in ACTA (28
      * De Gucht on ACTA being about public health, countering dangerous
        substances, purchase of medicines over the Internet (33:10
      * MEP Albrecht's question about safeguards in EU law (38:30
        minutes) and need for safeguards and exceptions in ACTA (41:40
      * Removal of the definition of "commercial scale" from ACTA
        (41:45) responding to question from MEP Lambridinis (36:30
      * De Gucht regarding explicit reference to TRIPS safeguards (45:50

Malini Aisola
Knowledge Ecology International
1621 Connecticut Avenue NW, Suite 500, Washington DC 20009
malini.aisola at keionline.org|Tel: +1.202.332.2670|Fax: +1.202.332.2673

More information about the Ip-health mailing list